معرفی
Prof.ssa Elda Favari is a Full-Time Associate Professor of Pharmacology at the Department of Food and Drug, University of Parma, Italy. Her research focuses on atherosclerosis physiology, cholesterol metabolism, and cellular cholesterol efflux processes. She has collaborated with international institutions in the USA, Australia, and Switzerland.
- PhD in Pharmacology and Toxicology (University of Parma, 2005)
- Academic Editor for the journal Medicine
- Member of Italian Society of Pharmacology, European Lipoprotein Club, and International Atherosclerosis Society
Her scientific contributions include over 50 peer-reviewed publications, an H-index of 23, and 16 Q1-journal publications from the last 15 years. Key research areas cover reverse cholesterol transport, PCSK9 mechanisms, and HDL functionality in diseases like familial hypercholesterolemia, cancer, and autoimmune disorders.
Recent Google Scholar publications (2023-2025) examine:
- HDL modulation through nutraceuticals and 3D-printed devices
- Immune checkpoint inhibitors in relation to lipid profiles
- PCSK9-lomitapide interactions in genetic lipid disorders
- Anti-ApoA-1 IgGs as atherogenic factors
- 2000: AstraZeneca Grant at SISA Congress
- 2011: National Research Grant for Lupus Study
She has held institutional roles including Student Orientation Delegate and serves on scientific committees for international congresses. Teaching spans Toxicology, Anticancer Chemotherapy, and Pharmacovigilance across Pharmacy, Food Safety, and Drug Sciences programs.
